GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

OVID · Dec 31, 2024

Ovid Therapeutics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001628280-25-011844General Corporate
Capex intensity50thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

12.54% · OPTIONAL · VALID

Operating cash generation50thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-9886.22% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

44.50% · CORE · NOT_ENOUGH_HISTORY

Operating margin75thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.operating_margin

-10933.75% · CORE · VALID

R&D intensity38thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

6495.94% · OPTIONAL · VALID

SBC intensity38thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1108.83% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History10 statesHistory building
Period transition

What moved in the state?

Capex Intensity Increased
Previous
-2.31%
Current
12.54%
Delta
14.86%
Cash Generation Decreased
Previous
-8674.57%
Current
-9886.22%
Delta
-1211.65%
Growth Decreased
Previous
58.76%
Current
44.50%
Delta
-14.26%
Profitability Decreased
Previous
-7645.09%
Current
-10933.75%
Delta
-3288.66%
R And D Intensity Increased
Previous
4540.46%
Current
6495.94%
Delta
1955.47%
Sbc Intensity Increased
Previous
756.07%
Current
1108.83%
Delta
352.76%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.